Peritoneal mesothelioma: a review

Alessio Bridda1, Ilaria Padoan, Roberto Mencarelli

  • 1Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy. alex@omniazone.com

Abstract

Insights

Malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer. Its natural history is poorly understood, despite ongoing asbestos exposure concerns and increasing incidence.

Area of Science:

  • Oncology
  • Public Health
  • Pathology

Background:

  • Malignant peritoneal mesothelioma (MPM) is a rare and aggressive malignancy originating in the peritoneum.
  • MPM is considered universally fatal, with limited understanding of its natural history.
  • Asbestos exposure remains a significant global public health issue, contributing to mesothelioma incidence.

Purpose of the Study:

  • To elucidate the natural history and clinical characteristics of malignant peritoneal mesothelioma.
  • To provide a comprehensive overview of MPM for improved understanding and management.
  • To highlight the association between asbestos exposure and MPM development.

Main Methods:

  • Literature review of existing studies on MPM.
  • Analysis of epidemiological data related to mesothelioma incidence.
  • Synthesis of current knowledge on MPM pathology and clinical presentation.

Main Results:

  • MPM accounts for only 20-33% of all mesotheliomas, with pleural mesothelioma being more common.
  • The incidence of MPM has shown an increase over the last two decades.
  • Limited data exists on the specific natural history and prognostic factors for MPM.

Conclusions:

  • Further research is crucial to better understand the natural history and improve outcomes for MPM.
  • Continued vigilance regarding asbestos exposure is necessary due to its link with mesothelioma.
  • Enhanced diagnostic and therapeutic strategies are needed for this rare and aggressive cancer.